SHILPAMED - Shilpa Medicare

Shilpa Medicare

SHILPAMED · Pharma > Pharmaceuticals & Drugs · Chairman: Omprakash Inani · MD: Vishnukant Bhutada · Listing date: Dec. 4, 2009 · Employees: 2350 · Raichur · http://www.vbshilpa.com

Stock Price vs Company Growth

2.7%

5.1%

4.5%

1.1%

23.8%

34.1%

12.7%

10y

4.1%

all

16.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 669 2.7%

530

730

Company Overview

Sales

1,247 Cr

Growth: 9.0%

Profit after Tax

82.2 Cr

Growth: 49.5%

Small Cap

6,539 Cr

P/E: 71.4x

Industry P/E: 31.8x

Fundamentals

Sales (Cr)	₹ 1,247
Growth	9.0%
EBITDA	24.9%
P/S	5.2x
Dividend	0.0%
P/E	71.4x
Book Value	₹ 192
PEG Ratio	8.0x
ROE	4.5%
P/B	3.5x

Shareholding Pattern

Institutions

Ta Fii Investors Fund

3.71 %

Tano Mauritius India Fvci Ii

2.43 %

Pivotal Enterprises Private Limited

2.35 %

Pivotal Business Managers Llp

1.75 %

Duro One Investments Limited

1.42 %

Promoters

Vishnukant Chaturbhuj Bhutada

7.81 %

Dharmavati Bhutada

7.61 %

Ravi Kumar Innani

4.91 %

Suraj Kumar Innani

4.88 %

Ramakant Innani

4.29 %

Others

Increase Decrease No change

Company Profile Detailed

Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Belongs to (10 Indices) view more

Investors (148)

india.op...

vishnuka...

jayesh.d...

Followers (8)

nitin2

keerthi

deepak